HOME >> BIOLOGY >> NEWS
Beware cancer, insomnia and liver disease UH students are taking aim

HOUSTON, June 1, 2004 Targeting a range of diseases and disorders, three University of Houston students won awards at a recent symposium for research in liver disease, cancer and insomnia.

The Intercultural Cancer Council (ICC) recently hosted its 9th Biennial Symposium on Minorities, the Medically Undeserved and Cancer in Washington, D.C. The ICC promotes policies, programs, partnerships and research to eliminate the unequal burden of cancer among racial and ethnic minorities and medically undeserved populations in the U.S. and its associated territories.

Among the 1,500 who attended this ICC symposium, UH students accounted for 18 of the 300 students from across the nation who participated. Three UH students from the College of Natural Sciences and Mathematics (NSM) swept the undergraduate research competition, taking home half of the six awards handed out in that category. Each received a medal to recognize their achievements and a cash award of $500.

"We are extremely proud of all our students who represented the University of Houston," said John Bear, dean of UH's College of Natural Sciences and Mathematics. "And we're particularly pleased with the acknowledgement received by our three outstanding students who presented award-winning work, as well as commend the faculty members for engaging undergraduates in the research process."

Jose Figueroa, a senior biology major in NSM's Biology and Biochemistry department at UH, won his poster award for research in biological clocks. Also known as circadian rhythms, biological clocks are the mechanisms that control sleep/wake cycles in living organisms. Working in the Neurobiology Laboratory with Michael Rea, UH professor of biology and biochemistry, Figueroa assists with the lab's focus on understanding the biological clock so that it may eventually lead to therapeutic agents that can treat sleeping/waking disorders, such as advanced sleep phase syndrome, jet lag and insomn
'"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
1-Jun-2004


Page: 1 2 3

Related biology news :

1. Beware of leap year when predicting climate change, warns researcher
2. Beware the frozen vegetable ice pack to ease pain
3. Beware The Pumpkin Preyer
4. IBD (Crohns, Colitis) joins cancer, inflammatory diseases in associated blood vessel growth
5. Purdue scientists: To stop cancer, keep your Icmt away from your Ras
6. Drug developed for rare disease may help millions more as treatment for cancer, autoimmune diseases
7. Telltale prostate cancer protein key to breast cancer, too
8. UGA receives $6.7 M grant that will add knowledge in fights against cancer, Parkinsons disease
9. Isolation of ferret protein promising for cancer, reproductive studies
10. UNC studies target molecular defects implicated in cancer, genetic diseases
11. Common human virus may be associated with colon cancer, according to Temple researchers

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Beware cancer insomnia and liver disease students are taking aim

(Date:7/7/2015)... Research and Markets ... the "Capacitive Fingerprint Sensors Patent Landscape" ... date, fingerprint sensing technology is the most reliable ... well developed. This patent landscape focuses on fingerprint ... domain of capacitive fingerprint sensors is closely linked ...
(Date:7/7/2015)... OXFORD, Conn. , July 7, 2015 NXT-ID, Inc. ... company focused on the growing mobile commerce market announces a revised ... airing this week. The commercial will air on CNBC in ... Los Angeles and San Francisco ... The commercial focuses on Wocket,s ability to replace all the ...
(Date:7/2/2015)... 25, 2015 Research and ... "Next Generation Biometrics Market by Application, Technology, Function ... to their offering. The next generation biometrics ... at a CAGR of 17.9% between 2015 and 2020 ... for the market. Safran SA ( ...
Breaking Biology News(10 mins):Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3
(Date:8/3/2015)... ... August 03, 2015 , ... Sterlitech Corporation introduces ... comprehensive line of analytical laboratory equipment. With optimized features, such as PTFE-coated contact ... chemically resistant and maintenance-free solution for a broad range of vacuum filtration applications. ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... the detection and quantification of partially hydrolyzed gluten in foods, has been accepted ... adopted the method “Partially Hydrolyzed Gluten in Fermented Cereal-Based Products by R5 Competitive ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... appointed Francois Vieillard as Sales & Marketing Director. , With more than ... will be responsible for reinforcing Tronics’ business development activities worldwide. He brings to ...
(Date:7/30/2015)... Kan. , July 30, 2015   ... a pet therapeutics company focused on the licensing, ... companion animals, today announced that its strategic partner ... a dose confirmation study of AT-016, an adipose-derived ... for the treatment of osteoarthritis pain in dogs. ...
Breaking Biology Technology:Sterlitech Launches New Line of Vacuum Pumps 2RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2Tronics appoints Francois Vieillard as Sales and Marketing Director 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5
Cached News: